The incidence of oxyphenisatin ingestion in active chronic hepatitis: a prospective controlled study of 29 patients.
D000328:Adult; D000368:Aged; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D002400:Cathartics / Q000008:administration & dosage* / Q000633:toxicity; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000201:enzymology / Q000209:etiology; D002908:Chronic Disease; D005260:Female; D006505:Hepatitis / Q000209:etiology*; D006801:Humans; D007211:Indoles / Q000008:administration & dosage* / Q000633:toxicity; D007659:Ketones / Q000008:administration & dosage / Q000633:toxicity; D008297:Male; D008875:Middle Aged; D010636:Phenols / Q000008:administration & dosage / Q000633:toxicity; D011446:Prospective Studies
D002400:Cathartics; D007211:Indoles; D007659:Ketones; D010636:Phenols; D001219:Aspartate Aminotransferases; D001663:Bilirubin